|
|
||||||||
The Journal of Immunology, Vol 153, Issue 5 1955-1962, Copyright © 1994 by American Association of Immunologists
ARTICLES |
TJ Fleming and TR Malek
Department of Microbiology and Immunology, University of Miami School of Medicine, FL 33101.
Cross-linking of Ly-6 molecules on T lymphocytes leads to IL-2 production, whereas costimulation of T cells via Ly-6A/E and the TCR inhibits IL-2 secretion. This study was initiated to determine whether there are unique structural requirements at the level of the Ly-6 molecule for its capacity to activate or block IL-2 production. Functional studies in which transfected EL-4J cells that expressed various Ly-6 proteins or chimeric Ly-6 molecules were used have demonstrated that direct activation of IL-2 secretion or inhibition of anti-CD3-induced IL-2 production occurred after mAb binding to Ly-6A/E, Ly-6C, and Ly-6G and was independent of whether the mAbs bound to amino- or carboxyl-terminal epitopes of Ly-6. The blockade of IL-2 production by costimulation with anti-CD3 and anti-Ly-6 was detected even when the addition of either mAb was temporally delayed for up to 17 h in a reciprocal fashion. Stimulation of mouse Ly-6 proteins expressed in Jurkat cells antagonized PMA/OKT3-induced IL-2 production, thus revealing that the Ly-6 inhibitory pathway is operative in human cells. EL-4J cells were also transfected with a chimeric construct in which the glycosylphosphatidylinositol anchor of Ly-6E was replaced by the transmembrane and a portion of the intracytoplasmic tail of H-2Db. Anti- Ly-6A/E also blocked anti-CD3-induced IL-2 production for these cells, although anti-Ly-6A/E failed to directly induce IL-2 secretion. Thus, anti-Ly-6A/E blockade of IL-2 production is independent of the glycosylphosphatidylinositol anchor of Ly-6E. This finding suggests that there may be aspects of signaling via Ly-6 that are solely dependent on the extracellular amino acid sequence of this protein.
This article has been cited by other articles:
![]() |
E. E. Tulin, N. Onoda, Y. Nakata, M. Maeda, M. Hasegawa, H. Nomura, and T. Kitamura SF20/IL-25, a Novel Bone Marrow Stroma-Derived Growth Factor That Binds to Mouse Thymic Shared Antigen-1 and Supports Lymphoid Cell Proliferation J. Immunol., December 1, 2001; 167(11): 6338 - 6347. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Marmor, M. F. Bachmann, P. S. Ohashi, T. R. Malek, and M. Julius Immobilization of glycosylphosphatidylinositol-anchored proteins inhibits T cell growth but not function Int. Immunol., September 1, 1999; 11(9): 1381 - 1393. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Shan, A. Bourdeau, A. Rhoton, D. E. Wells, E. H. Cohen, B. E. Landgraf, and R. G. E. Palfree Characterization and Mapping to Human Chromosome 8q24.3 of Ly-6-Related Gene 9804 Encoding an Apparent Homologue of Mouse TSA-1 J. Immunol., January 1, 1998; 160(1): 197 - 208. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Stulnig, M. Berger, T. Sigmund, H. Stockinger, V. Horejsi, and W. Waldhausl Signal Transduction via Glycosyl Phosphatidylinositol-anchored Proteins in T Cells Is Inhibited by Lowering Cellular Cholesterol J. Biol. Chem., August 1, 1997; 272(31): 19242 - 19247. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |